Multidisciplinary tumor board decision-making for postoperative radiotherapy in thymic epithelial tumors: Insights from the RYTHMIC prospective cohort.

Fiche publication

Date publication

juillet 2017

Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CLEMENT-DUCHENE Christelle , Pr WESTEEL Virginie

Tous les auteurs :
Basse C, Thureau S, Bota S, Dansin E, Thomas PA, Pichon E, Lena H, Massabeau C, Clement-Duchene C, Massard G, Westeel V, Quantin X, Oulkhouir Y, Danhier S, Lerouge D, Tanguy R, Thillays F, Le Pechoux C, Dubray B, Thiberville L, Besse B, Girard N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28774861

Résumé

Thymic Epithelial Tumors (TET) are rare intrathoracic malignancies for which surgery represents the mainstay of the treatment. Current practice for postoperative radiotherapy (PORT) is highly variable and there is a lack of prospective, high level evidence. RYTHMIC is the nationwide network for TET in France established in 2012, which prospectively collects data for all TET patients, for whom management is discussed at a national multidisciplinary tumor board (MTB). We assessed whether postoperative radiotherapy (PORT) decisions at the MTB were in accordance with RYTHMIC guidelines, and ultimately implemented in patients.